Nine Chapters Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-6,400
Closed -$269K 1007
2013
Q2
$269K Buy
+6,400
New +$269K 0.05% 477